Ningbo Menovo Pharmaceutical Co., Ltd. (SHA:603538)
China · Delayed Price · Currency is CNY 26.45
-0.75 (-2.76%)
Sep 10, 2026, 2:45 PM CST
SHA:603538 Revenue
Ningbo Menovo Pharmaceutical had revenue of 521.17M CNY in the quarter ending June 30, 2026, with 30.02% growth. This brings the company's revenue in the last twelve months to 1.68B, up 16.80% year-over-year. In the year 2025, Ningbo Menovo Pharmaceutical had annual revenue of 1.50B with 9.49% growth.
Revenue (ttm)
1.68B
Revenue Growth
+16.80%
P/S Ratio
5.49
Revenue / Employee
710.81K
Employees
2,370
Market Cap
9.25B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.50B | 130.27M | 9.49% |
| Dec 31, 2024 | 1.37B | 156.36M | 12.85% |
| Dec 31, 2023 | 1.22B | -240.48M | -16.51% |
| Dec 31, 2022 | 1.46B | 198.83M | 15.80% |
| Dec 31, 2021 | 1.26B | 64.77M | 5.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.